In the winter issue of Gut Reaction the IBS Network’s Christine Dancey reported on research she carried out on a new neutraceutical, IntestAidB, which contains nucleotides - substances, produced in the body and important for the growth of cells that have a rapid turnover, such as those in the immune system and the gastrointestinal tract.

Healthy people are able to get sufficient nucleotides from their food; lamb, liver and mushrooms are particularly rich in nucleotides. The question was whether supplemented nucleotides might improve immune and gastrointestinal function in people who were unwell.

Over a 20-week period those on the trial took IntestAidB or a placebo, interspersed with ‘washout’ periods. The results did show ‘significant statistical improvement’ for those on the supplements in relation to abdominal pain, urgency to have a bowel movement and the feeling of incomplete evacuation.

This of course was an averaged out result - within the group some people improved considerably whereas others improved scarcely at all. However, the added benefit for all concerned that is that IntestAidB, is a neutraceutical and has no known side effects.

The research was published in Nutrition Journal last year: Dancey CUP et al (2006) Nucleotide Supplementation: a RDBPC trial of IntestAidB for IBS Nutrition Journal, 5:16

Read more


Click here for more research on the management IBS


Top of page

If you found this article interesting, you will find many more general articles and research reports on coeliac disease here, and lots of information on the management of coeliac disease here.
You can also find articles and research reports on gluten intolerance here and articles on a wide range of other digestive conditions here.

For hundreds of gluten free foods see our freefrom food section here, and for nearly 800 gluten-free recipes see here.

And if you would like to get our FREE fortnightly e-newsletter with new products, recipes, articles and all the latest news from the allergy and freefrom world, just sign up here.